文献速递心境障碍

重度抑郁症患者脑内5-HT4受体结合降低且与记忆功能障碍相关

Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction.
PubMed 文献 · JAMA Psychiatry · 2023-01-01

该病例对照研究纳入90例未用药中重度抑郁症门诊患者和91名健康对照,采用[11C]SB207145 PET定量脑内5-HT4受体结合。提示脑内5-HT4受体是改善抑郁症记忆功能障碍的潜在治疗靶点。

要点

  • 未用药中重度抑郁症患者脑内5-HT4受体结合较健康对照降低7.0%。
  • 5-HT4受体是改善抑郁症记忆功能障碍的潜在治疗靶点。

核心结论

  • 抑郁症患者脑内5-HT4受体结合低于健康对照,且记忆功能障碍与较低的5-HT4受体结合相关。

研究设计与样本

  • 病例对照研究,使用丹麦NeuroPharm临床试验基线数据,纳入90例未用药中重度抑郁症门诊患者和91名健康对照。

临床怎么用

  • 脑内5-HT4受体可作为改善抑郁症记忆功能障碍的潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The cerebral serotonin 4 (5-HT4) receptor is a promising novel target for treatment of major depressive disorder (MDD), and pharmacological stimulation of the 5-HT4 receptor has been associated with improved learning and memory in healthy individuals. OBJECTIVE: To map the neurobiological signatures of patients with untreated MDD compared with healthy controls and to examine the association between cerebral 5-HT4 receptor binding and cognitive functions in the depressed state. DESIGN, SETTING, AND PARTICIPANTS: This case-control study used baseline data from the NeuroPharm clinical depression trial in Denmark. Adult participants included antidepressant-free outpatients with a current moderate to severe depressive episode and healthy controls. All participants completed positron emission tomography (PET) scanning with [11C]SB207145 for quantification of brain 5-HT4 receptor binding, but only the patients underwent cognitive testing. Data analyses were performed from January 21, 2020, to April 22, 2022. MAIN OUTCOMES AND MEASURES: The main study outcome was the group difference in cerebral 5-HT4 receptor binding between patients with MDD and healthy controls. In addition, the association between 5-HT4 receptor binding and verbal memory performance in the patient group was tested. Other cognitive domains (working memory, reaction time, emotion recognition bias, and negative social emotions) were assessed as secondary outcomes. RESULTS: A total of 90 patients with untreated MDD (mean [SD] age, 27.1 [8.2] years; 64 women [71.1%]) and 91 healthy controls (mean [SD] age, 27.1 [8.0] years; 55 women [60.4%]) were included in the analysis. Patients with current MDD had significantly lower cerebral 5-HT4 receptor binding than healthy controls (-7.0%; 95% CI, -11.2 to -2.7; P = .002). In patients with MDD, there was a correlation between cerebral 5-HT4 receptor binding and verbal memory (r = 0.29; P = .02). CONCLUSIONS AND RELEVANCE: Results of this study show that cerebral 5-HT4 receptor binding was lower in patients with MDD than in healthy controls and that the memory dysfunction in patients with MDD was associated with lower cerebral 5-HT4 receptor binding. The cerebral 5-HT4 receptor is a promising treatment target for memory dysfunction in patients with MDD.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Köhler-Forsberg K, Dam VH, Ozenne B, et al. Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction. JAMA Psychiatry. 2023. PMID: 36753296. doi:10.1001/jamapsychiatry.2022.4539

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。